Integrated BioPharma, Inc. (INBP)
- Previous Close
0.2150 - Open
0.1806 - Bid --
- Ask --
- Day's Range
0.2150 - 0.2150 - 52 Week Range
0.1700 - 0.3800 - Volume
600 - Avg. Volume
3,216 - Market Cap (intraday)
6.471M - Beta (5Y Monthly) 0.51
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date May 6, 2024 - May 10, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
www.ibiopharma.comRecent News: INBP
Performance Overview: INBP
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INBP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INBP
Valuation Measures
Market Cap
6.47M
Enterprise Value
8.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.13
Price/Book (mrq)
0.35
Enterprise Value/Revenue
0.16
Enterprise Value/EBITDA
33.87
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.76%
Return on Assets (ttm)
-0.93%
Return on Equity (ttm)
-2.07%
Revenue (ttm)
50.52M
Net Income Avi to Common (ttm)
-385k
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
732k
Total Debt/Equity (mrq)
12.25%
Levered Free Cash Flow (ttm)
699.38k
Company Insights: INBP
INBP does not have Company Insights